These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1891217

  • 1. Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients.
    Lee PY, Shao H, Camras CB, Podos SM.
    Ophthalmology; 1991 Jul; 98(7):1079-82. PubMed ID: 1891217
    [Abstract] [Full Text] [Related]

  • 2. The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma.
    Villumsen J, Alm A.
    Arch Ophthalmol; 1990 Aug; 108(8):1102-5. PubMed ID: 2383198
    [Abstract] [Full Text] [Related]

  • 3. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
    Camras CB, Siebold EC, Lustgarten JS, Serle JB, Frisch SC, Podos SM, Bito LZ.
    Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
    [Abstract] [Full Text] [Related]

  • 4. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
    Stewart WC, Stewart JA, Kapik BM.
    J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
    [Abstract] [Full Text] [Related]

  • 5. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [Abstract] [Full Text] [Related]

  • 6. Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study.
    Nagasubramanian S, Hitchings RA, Demailly P, Chuniaud M, Pannarale MR, Pecori-Giraldi J, Stodtmeister R, Parsons DG.
    Ophthalmology; 1993 Sep; 100(9):1318-23. PubMed ID: 8371918
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC, Ritch R, Shin DH, Lehmann RP, Shrader CE, van Buskirk EM.
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 11. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y, Tanino T, Kimura I, Mashima Y, Oguchi Y.
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [Abstract] [Full Text] [Related]

  • 12. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
    Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA, Travoprost Study Group.
    Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
    [Abstract] [Full Text] [Related]

  • 13. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
    Denis P, Andrew R, Wells D, Friren B.
    Eur J Ophthalmol; 2006 May; 16(3):407-15. PubMed ID: 16761242
    [Abstract] [Full Text] [Related]

  • 14. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG, Maltezos A, Mantziris DA, Sine CS, Stewart WC.
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [Abstract] [Full Text] [Related]

  • 15. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN, Scassellati Sforzolini B, Vittitow J, Liebmann J.
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [Abstract] [Full Text] [Related]

  • 16. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
    Mishima HK, Masuda K, Kitazawa Y, Azuma I, Araie M.
    Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
    Hommer A, Kapik B, Shams N, Unoprostone Adjunctive Therapy Study Group.
    Br J Ophthalmol; 2003 May; 87(5):592-8. PubMed ID: 12714402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
    Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, Bimatoprost Study Group.
    Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.